News

Click the title above to open the Applied Clinical Trials March 2019 issue in an interactive PDF format.

Patient advocacy organizations are swaying away from a traditional model of granting academic researchers to now supporting biotechnology and pharma companies.

Patient advocacy groups, patient centricity initiatives, and patient education are the key to putting patients at the center of clinical research.

In this Q&A, Helen Matthews, Jessica Morris, and Bruce Hellman offer their perspectives on the priorities, opportunities, and challenges of patient centricity in real-world evidence collection.

Optimization model evaluates the benefits of selecting a portfolio of investigative sites based on advanced analytical models.

Examining the distinct actions and advocacy that have advanced the concept from buzzword status to practical implementation in clinical studies.

It’s time to establish standard practices to return clinical trial results summaries to patients.

Europe is gradually attempting to maximize the potential of the scattered data that, if brought together, might help improve diagnosis and treatment of Europe's 30 million rare disease patients.

Reflections explored during the mid-February EFGCP conference in Brussels on making clinical research an element of better healthcare.

Sponsors have been addressing the problem with initiatives designed to find, attract, and retain patients in clinical trials more effectively.

A review of survey results looking at bridging clinical research and clinical health care.